[u'-----BEGIN PRIVACY-ENHANCED MESSAGE-----\nProc-Type: 2001,MIC-CLEAR\nOriginator-Name: webmaster@www.sec.gov\nOriginator-Key-Asymmetric:\n MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen\n TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB\nMIC-Info: RSA-MD5,RSA,\n OQI3qsQAz9QypkbNwwyAc9B9qZLApDL/rr4W5DbVk76l+BtSChBNd+/13Qbsjd1M\n vrEeXmgLR07Ji0uw59+whg==\n\n', u'0001104659-04-026574.txt : 20040901\n', u'0001104659-04-026574.hdr.sgml : 20040901\n', u'20040901122503\nACCESSION NUMBER:\t\t0001104659-04-026574\nCONFORMED SUBMISSION TYPE:\t8-K\nPUBLIC DOCUMENT COUNT:\t\t3\nCONFORMED PERIOD OF REPORT:\t20040830\nITEM INFORMATION:\t\tResults of Operations and Financial Condition\nITEM INFORMATION:\t\tFinancial Statements and Exhibits\nFILED AS OF DATE:\t\t20040901\nDATE AS OF CHANGE:\t\t20040901\n\nFILER:\n\n\tCOMPANY DATA:\t\n\t\tCOMPANY CONFORMED NAME:\t\t\tIOMED INC\n\t\tCENTRAL INDEX KEY:\t\t\t0001041652\n\t\tSTANDARD INDUSTRIAL CLASSIFICATION:\tPHARMACEUTICAL PREPARATIONS [2834]\n\t\tIRS NUMBER:\t\t\t\t870441272\n\t\tSTATE OF INCORPORATION:\t\t\tUT\n\t\tFISCAL YEAR END:\t\t\t0630\n\n\tFILING VALUES:\n\t\tFORM TYPE:\t\t8-K\n\t\tSEC ACT:\t\t1934 Act\n\t\tSEC FILE NUMBER:\t001-14059\n\t\tFILM NUMBER:\t\t041010338\n\n\tBUSINESS ADDRESS:\t\n\t\tSTREET 1:\t\t3385 WEST 1820 SOUTH\n\t\tCITY:\t\t\tSALT LAKE CITY\n\t\tSTATE:\t\t\tUT\n\t\tZIP:\t\t\t84104\n\t\tBUSINESS PHONE:\t\t8019751191\n\n\tMAIL ADDRESS:\t\n\t\tSTREET 1:\t\t3385 WEST 1820 SOUTH\n\t\tSTREET 2:\t\t3385 WEST 1820 SOUTH\n\t\tCITY:\t\t\tSALT LAKE CITY\n\t\tSTATE:\t\t\tUT\n\t\tZIP:\t\t\t84104\n', u'\n', u'\n', u'8-K\n', u'1\n', u'a04-10097_18k.htm\n', u'8-K\n', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'UNITED STATES', u'\n', u'SECURITIES AND EXCHANGE\nCOMMISSION', u'\n', u'Washington,\nD.C.\xa0 20549', u'\n', u'\xa0', u'\n', u'FORM 8-K', u'\n', u'\xa0', u'\n', u'CURRENT REPORT', u'\n', u'\xa0', u'\n', u'PURSUANT\nTO SECTION 13 OR 15(d) OF THE SECURITIES', u'\n', u'EXCHANGE\nACT OF 1934', u'\n', u'\n', u'\n', u'\n', u'Date\nof Report (Date of earliest event reported): ', u'August 30,\n2004', u'\n', u'\xa0', u'\n', u'IOMED,\nInc.', u'\n', u'(Exact\nname of registrant as specified in its charter)', u'\n', u'\xa0', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'\n', u'Utah', u'\n', u'\n', u'\n', u'1-14059', u'\n', u'\n', u'\n', u'87-0441272', u'\n', u'\n', u'\n', u'\n', u'\n', u'(State\n  or other jurisdiction of', u'\n  Incorporation or organization)', u'\n', u'\n', u'\n', u'(Commission', u'\n  File Number) ', u'\n', u'\n', u'\n', u'(I.R.S.\n  Employer', u'\xa0Identification No.)', u'\n', u'\n', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'\n', u'2441 South 3850 West, Salt Lake City, Utah', u'\n', u'\n', u'\n', u'84120', u'\n', u'\n', u'\n', u'\n', u'\n', u'(Address\n  of principal executive offices)', u'\n', u'\n', u'\n', u'(Zip\n  Code)', u'\n', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\xa0', u'\n', u'(801)\n975-1191', u'\n', u'(Registrant\x92s\ntelephone number, including area code)', u'\n', u'\xa0', u'\n', u'\xa0', u'\n', u'N/A', u'\n', u'(Former\nname or former address, if changed since last report)', u'\n', u'\xa0', u'\n', u'Check the appropriate box\nbelow if the Form 8-K filing is intended to simultaneously satisfy the filing\nobligation of the registrant under any of the following provisions:', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'\n', u'\n', u'o', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'Written communications\n  pursuant to Rule 425 under the Securities Act (17 CFR 230.425)', u'\n', u'\n', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'\n', u'\n', u'o', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'\xa0Soliciting material pursuant to Rule 14a-12\n  under the Exchange Act (17 CFR 240.14a-12)', u'\n', u'\n', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'\n', u'\n', u'o', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'Pre-commencement communications pursuant to Rule 14d-2(b) under the\n  Exchange Act (17 CFR 240.14d-2(b))', u'\n', u'\n', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'\n', u'\n', u'o', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'Pre-commencement communication pursuant to Rule 13e-4(c) under the\n  Exchange Act (17 CFR 240.13e-4(c))', u'\n', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'\n', u" SEQ.=1,FOLIO='',FILE='C:\\JMS\\creyer\\04-10097-1\\task179952\\10097-1-ba.htm',USER='creyer',CD='Sep  1 00:31 2004' ", u'\n', u'\n', u'\xa0', u'\n', u'Item 2.02\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0 Results\nof Operations and Financial Condition', u'\n', u'\xa0', u'\n', u'The\ninformation contained in this Item 2.02 and the exhibit hereto are being\nfurnished and shall not be deemed \x93filed\x94 for purposes of Section 18 of the\nSecurities Exchange Act of 1934, and shall not be deemed incorporated by\nreference in any filing with the Securities and Exchange Commission under the\nSecurities Exchange Act of 1934 or the Securities Act of 1933, whether made\nbefore or after the date hereof and irrespective of any general incorporation\nlanguage in any filings.', u'\n', u'\xa0', u'\n', u'On\nAugust 30, 2004, the Company issued a press release announcing financial\nresults for the fourth quarter and fiscal year ended June 30, 2004.\xa0 The press release is attached as Exhibit 99.1\nto this Current Report on Form 8-K.', u'\n', u'\xa0', u'\n', u'Item\n9.01', u'\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0 ', u'\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0 Financial\nStatements and Exhibits', u'\n', u'\xa0', u'\n', u'(c)\nExhibits.', u'\n', u'\xa0', u'\n', u'The following exhibits are furnished with this Current Report on Form\n8-K:', u'\n', u'\xa0', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'\n', u'Exhibit', u'\n  Number', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'Description', u'\n', u'\n', u'\n', u'\n', u'\n', u'99.1*', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'Press Release Dated August\n  30, 2004.', u'\n', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'\n', u'* This information shall not\nbe deemed \x93filed\x94 for the purposes of Section 18 of the Securities Exchange Act\nof 1934, and shall not be deemed incorporated by reference in any filing with\nthe Securities and Exchange Commission under the Securities Exchange Act of\n1934 or the Securities Act of 1933, whether made before or after the date\nhereof and irrespective of any general incorporation language in any filings.', u'\n', u'\xa0', u'\n', u'\xa0', u'\n', u'2', u'\n', u'\n', u'\n', u'\n', u" SEQ.=1,FOLIO='',FILE='C:\\JMS\\creyer\\04-10097-1\\task179952\\10097-1-ba.htm',USER='creyer',CD='Sep  1 00:31 2004' ", u'\n', u'\n', u'\xa0', u'\n', u'Signature', u'\n', u'\xa0', u'\n', u'Pursuant\nto the requirements of the Securities Exchange Act of 1934, the registrant has\nduly caused this report to be signed on its behalf by the undersigned hereunto\nduly authorized.', u'\n', u'\xa0', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'\n', u'\n', u'DATED: August 31, 2004', u'\n', u'\n', u'\n', u'Iomed, Inc.', u'\n', u'\n', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'By:', u'\n', u'\n', u'\n', u'/s/ Robert J. Lollini', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'Robert J. Lollini', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'President and Chief Executive Officer', u'\n', u'\n', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\xa0', u'\n', u'\xa0', u'\n', u'3', u'\n', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\xa0', u'\n', u'\xa0', u'\n', u'\n', u" SEQ.=1,FOLIO='',FILE='C:\\JMS\\creyer\\04-10097-1\\task179952\\10097-1-ba.htm',USER='creyer',CD='Sep  1 00:31 2004' ", u'\n', u'\n', u'\n', u'\n', u'EX-99.1\n', u'2\n', u'a04-10097_1ex99d1.htm\n', u'EX-99.1\n', u'\n', u'\n', u'\xa0', u'\n', u'EXHIBIT\n99.1', u'\n', u'\n', u'\xa0', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'\n', u'Company Contacts:', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'\n', u'\n', u'Robert J. Lollini', u'\n', u'\n', u'\n', u'Betsy Truax', u'\n', u'\n', u'\n', u'\n', u'\n', u'President & CEO', u'\n', u'\n', u'\n', u'Investor Relations\n  Consultant', u'\n', u'\n', u'\n', u'\n', u'\n', u'(801) 975-1191', u'\n', u'\n', u'\n', u'(801) 975-1191, ext. 411', u'\n', u'\n', u'\n', u'\n', u'\n', u'www.iomed.com', u'\n', u'\n', u'\n', u'info@iomed.com', u'\n', u'\n', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'IOMED\nReports Fourth Quarter and Fiscal 2004 Operating Results', u'\n', u'\xa0', u'\n', u'Record Sales and Net Income', u'\n', u'\xa0', u'\n', u'Salt Lake City, UT (August 30,\n2004) \x97 IOMED, Inc.', u' (AMEX:IOX) today reported financial results for the\nfourth quarter and fiscal year ended June 30, 2004. The Company posted record\nquarterly and annual sales and net income, as well as positive operating cash\nflow.', u'\n', u'\xa0', u'\n', u'Fourth Quarter Results', u'\n', u'For the quarter ended June 30, 2004, sales\nwere $3,163,000, marking the third consecutive quarter of sales in excess of $3\nmillion. Revenues from increased unit volume were offset, in part, by dealer\nprice incentives introduced during the quarter. Gross margin was 62% compared\nwith 64% a year ago.', u'\n', u'\xa0', u'\n', u'Total operating expenses of $1,603,000 were\ndown 8% from the prior-year quarter. Selling, general and administrative\nexpenses decreased 12% during the quarter, while the Company\x92s investment in\nresearch and new product development increased 18%.', u'\n', u'\xa0', u'\n', u'For the fourth quarter of fiscal 2004, net\nincome increased 22% to $344,000, or $0.04 per diluted share, representing an\n11% return on sales. This compared with net income of $282,000, or $0.04 per\ndiluted share, a year ago. IOMED has reported net income for eight consecutive\nquarters.', u'\n', u'\xa0', u'\n', u'Fiscal 2004 Operating Results', u'\n', u'For the fiscal year ended June 30, 2004,\nIOMED reported sales of $12,189,000 compared with $11,935,000 a year ago. Gross\nmargin was 62% compared with 63% a year ago. The decrease in gross profit\nmargin was due, in part, to dealer price incentives introduced during the\nfourth quarter. Selling, general and administrative expenses decreased 2%,\nwhile research and development expenses decreased 15%. For fiscal 2004, IOMED\nreported net income of $954,000, or $0.12 per diluted share, a 22% increase\nover net income of $785,000, or $0.10 per diluted share, for the prior year.', u'\n', u'\xa0', u'\n', u'IOMED generated operating cash flow of $1.4\nmillion for fiscal 2004. Working capital increased to $8.2 million and\nshareholders\x92 equity reached $9.4 million. Total cash as of June 30, 2004 was\n$8.4 million.', u'\n', u'\xa0', u'\n', u'Management Comments', u'\n', u'\x93We are pleased to have reported net income\nover the last eight consecutive quarters, while generating over $3.1 million of\noperating cash flow during that period. During fiscal 2004, we', u'\n', u'\xa0', u'\n', u'\xa0', u'\n', u'1', u'\n', u'\n', u'\n', u'\n', u" SEQ.=1,FOLIO='1',FILE='C:\\JMS\\creyer\\04-10097-1\\task179970\\10097-1-kg.htm',USER='creyer',CD='Sep  1 01:08 2004' ", u'\n', u'\n', u'\xa0', u'\n', u'increased working capital by $1.9 million and\nadded $1 million to shareholders\x92 equity. Also during the year, we introduced\nthree new products and restructured our distribution network. Looking forward,\nwe will continue to strengthen our product line and distribution relationships\nand seek new opportunities to broaden our revenue base,\x94 said Mr. Robert J.\nLollini, IOMED President and CEO.', u'\n', u'\xa0', u'\n', u'IOMED is a leader in developing,\nmanufacturing and marketing active drug delivery systems used primarily to\ntreat acute local inflammation in the physical and occupational therapy and\nsports medicine markets. The Company is pursuing opportunities to advance its\nposition as a provider of quality, innovative non-invasive medical products\nthat improve patient healthcare. IOMED seeks to accomplish this by expanding\nits product line, distributing new products, developing strategic partnerships,\nand through acquisition.', u'\n', u'\xa0', u'\n', u'The statements contained in this news release that are not purely\nhistorical are forward-looking statements, as defined in Section 27A of the\nSecurities Act of 1933 and Section 21E of the Securities Exchange Act of 1934,\nand include IOMED\x92s beliefs, expectations or intentions regarding its future\noperations and financial condition. All forward-looking statements included in\nthis news release are made as of the date hereof and are based upon information\navailable to IOMED as of such date. IOMED assumes no obligation to update any\nforward-looking statement. It is important to note that actual outcomes could\ndiffer materially from those in such forward-looking statements. Readers should\nalso refer to the risk factors and other disclosures set forth in IOMED\x92s\nfilings with the Securities Exchange Commission on Form 10-K for its fiscal\nyear ended June 30, 2003.', u'\n', u'\x97TABLES FOLLOW\x97', u'\n', u'2', u'\n', u'\n', u'\n', u'\n', u" SEQ.=1,FOLIO='2',FILE='C:\\JMS\\creyer\\04-10097-1\\task179970\\10097-1-kg.htm',USER='creyer',CD='Sep  1 01:08 2004' ", u'\n', u'\n', u'\xa0', u'\n', u'CONDENSED CONSOLIDATED STATEMENTS', u'\n', u'OF\nOPERATIONS', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'Three Months Ended ', u'\n', u'June 30,', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'Twelve Months Ended ', u'\n', u'June 30,', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'2004', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'2003', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'2004', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'2003', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'(unaudited)', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'(audited)', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'(unaudited)', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'\n', u'\n', u'Product sales', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'$', u'\n', u'\n', u'\n', u'3,163,000', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'$', u'\n', u'\n', u'\n', u'3,120,000', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'$', u'\n', u'\n', u'\n', u'12,189,000', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'$', u'\n', u'\n', u'\n', u'11,935,000', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'\n', u'\n', u'Cost of products sold', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'1,216,000', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'1,135,000', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'4,607,000', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'4,376,000', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'\n', u'\n', u'Gross profit', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'1,947,000', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'1,985,000', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'7,582,000', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'7,559,000', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'\n', u'\n', u'Operating costs and expenses:', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'\n', u'\n', u'Selling, general and administrative', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'1,318,000', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'1,499,000', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'5,593,000', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'5,711,000', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'\n', u'\n', u'Research and development', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'285,000', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'242,000', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'1,050,000', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'1,232,000', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'\n', u'\n', u'Non-recurring items', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'\x97', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'\x97', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'\x97', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'(76,000', u'\n', u'\n', u'\n', u')', u'\n', u'\n', u'\n', u'\n', u'\n', u'Total operating costs and expenses', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'1,603,000', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'1,741,000', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'6,643,000', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'6,867,000', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'\n', u'\n', u'Operating income', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'344,000', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'244,000', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'939,000', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'692,000', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'\n', u'\n', u'Other income (expense):', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'\n', u'\n', u'Interest expense', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'(36,000', u'\n', u'\n', u'\n', u')', u'\n', u'\n', u'\n', u'(45,000', u'\n', u'\n', u'\n', u')', u'\n', u'\n', u'\n', u'(169,000', u'\n', u'\n', u'\n', u')', u'\n', u'\n', u'\n', u'(213,000', u'\n', u'\n', u'\n', u')', u'\n', u'\n', u'\n', u'\n', u'\n', u'Interest income and other, net', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'36,000', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'83,000', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'184,000', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'306,000', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'\n', u'\n', u'Net income', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'$', u'\n', u'\n', u'\n', u'344,000', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'$', u'\n', u'\n', u'\n', u'282,000', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'$', u'\n', u'\n', u'\n', u'954,000', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'$', u'\n', u'\n', u'\n', u'785,000', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'\n', u'\n', u'Income per share:', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'\n', u'\n', u'Basic', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'$', u'\n', u'\n', u'\n', u'0.05', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'$', u'\n', u'\n', u'\n', u'0.04', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'$', u'\n', u'\n', u'\n', u'0.15', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'$', u'\n', u'\n', u'\n', u'0.12', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'\n', u'\n', u'Diluted', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'$', u'\n', u'\n', u'\n', u'0.04', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'$', u'\n', u'\n', u'\n', u'0.04', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'$', u'\n', u'\n', u'\n', u'0.12', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'$', u'\n', u'\n', u'\n', u'0.10', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'\n', u'\n', u'Shares used in the computation of income per share:', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'\n', u'\n', u'Basic', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'6,579,000', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'6,545,000', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'6,559,000', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'6,545,000', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'\n', u'\n', u'Diluted', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'7,906,000', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'7,539,000', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'7,708,000', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'7,497,000', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'\n', u'\n', u'\n', u'\n', u'\n', u'\n', u'\n', u'\n', u'\n', u'\n', u'\n', u'\n', u'\n', u'\n', u'\n', u'\n', u'\n', u'\n', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\xa0', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'June 30,', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'June 30,', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'\n', u'\n', u'Consolidated Balance Sheet', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'2004', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'2003', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'(unaudited)', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'(audited)', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'\n', u'\n', u'Cash and cash equivalents', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'$', u'\n', u'\n', u'\n', u'7,338,000', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'$', u'\n', u'\n', u'\n', u'5,921,000', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'\n', u'\n', u'Working capital, net', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'$', u'\n', u'\n', u'\n', u'8,173,000', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'$', u'\n', u'\n', u'\n', u'6,263,000', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'\n', u'\n', u'Restricted cash', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'$', u'\n', u'\n', u'\n', u'1,062,000', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'$', u'\n', u'\n', u'\n', u'1,689,000', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'\n', u'\n', u'Total assets', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'$', u'\n', u'\n', u'\n', u'12,511,000', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'$', u'\n', u'\n', u'\n', u'12,491,000', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'\n', u'\n', u'Long-term obligations', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'$', u'\n', u'\n', u'\n', u'1,368,000', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'$', u'\n', u'\n', u'\n', u'1,971,000', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'\n', u'\n', u'Accumulated deficit', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'$', u'\n', u'\n', u'\n', u'(32,157,000', u'\n', u'\n', u'\n', u')', u'\n', u'\n', u'\n', u'$', u'\n', u'\n', u'\n', u'(33,111,000', u'\n', u'\n', u'\n', u')', u'\n', u'\n', u'\n', u'\n', u'\n', u'Shareholders\x92 equity', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'$', u'\n', u'\n', u'\n', u'9,443,000', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'$', u'\n', u'\n', u'\n', u'8,416,000', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'\n', u'\n', u'\n', u'\n', u'\n', u'\n', u'\n', u'\n', u'\n', u'\n', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\xa0', u'\n', u'\xa0', u'\n', u'3', u'\n', u'\n', u'\n', u'\n', u" SEQ.=1,FOLIO='3',FILE='C:\\JMS\\creyer\\04-10097-1\\task179970\\10097-1-kg.htm',USER='creyer',CD='Sep  1 01:08 2004' ", u'\n', u'\n', u'\xa0', u'\n', u'CONDENSED CONSOLIDATED STATEMENTS', u'\n', u'OF CASH FLOWS', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'Twelve\n  Months Ended', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'June 30,', u'\n  2004', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'2003', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'(unaudited)', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'\n', u'\n', u'Cash flows from operating activities', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'\n', u'\n', u'Net income', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'$', u'\n', u'\n', u'\n', u'954,000', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'$', u'\n', u'\n', u'\n', u'785,000', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'\n', u'\n', u'Adjustments to reconcile net income to net cash provided by operating\n  activities:', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'\n', u'\n', u'Depreciation and amortization', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'954,000', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'955,000', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'\n', u'\n', u'Other non-cash charges', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'\x97', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'(76,000', u'\n', u'\n', u'\n', u')', u'\n', u'\n', u'\n', u'\n', u'\n', u'Changes in operating assets and liabilities:', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'\n', u'\n', u'Accounts receivable', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'(47,000', u'\n', u'\n', u'\n', u')', u'\n', u'\n', u'\n', u'(107,000', u'\n', u'\n', u'\n', u')', u'\n', u'\n', u'\n', u'\n', u'\n', u'Inventories', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'(68,000', u'\n', u'\n', u'\n', u')', u'\n', u'\n', u'\n', u'(146,000', u'\n', u'\n', u'\n', u')', u'\n', u'\n', u'\n', u'\n', u'\n', u'Prepaid expenses', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'26,000', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'(5,000', u'\n', u'\n', u'\n', u')', u'\n', u'\n', u'\n', u'\n', u'\n', u'Trade accounts payable', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'(56,000', u'\n', u'\n', u'\n', u')', u'\n', u'\n', u'\n', u'195,000', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'\n', u'\n', u'Other accrued liabilities', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'(353,000', u'\n', u'\n', u'\n', u')', u'\n', u'\n', u'\n', u'64,000', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'\n', u'\n', u'Net cash provide by operating activities', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'1,410,000', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'1,665,000', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'\n', u'\n', u'Cash flows from investing activities', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'\n', u'\n', u'Purchases of equipment and furniture', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'(95,000', u'\n', u'\n', u'\n', u')', u'\n', u'\n', u'\n', u'(200,000', u'\n', u'\n', u'\n', u')', u'\n', u'\n', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'\n', u'\n', u'Cash flows from financing activities', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'\n', u'\n', u'Change in restricted cash balance', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'627,000', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'590,000', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'\n', u'\n', u'Proceeds from exercise of stock options', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'73,000', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'\x97', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'\n', u'\n', u'Payments on long-term obligations', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'(598,000', u'\n', u'\n', u'\n', u')', u'\n', u'\n', u'\n', u'(556,000', u'\n', u'\n', u'\n', u')', u'\n', u'\n', u'\n', u'\n', u'\n', u'Net cash used in financing activities', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'102,000', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'34,000', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'\n', u'\n', u'Net increase in cash and cash equivalents', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'1,417,000', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'1,499,000', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'\n', u'\n', u'Cash and cash equivalents at beginning of period', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'5,921,000', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'4,422,000', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'\n', u'\n', u'Cash and cash equivalents at end of period', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'$', u'\n', u'\n', u'\n', u'7,338,000', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'$', u'\n', u'\n', u'\n', u'5,921,000', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\xa0', u'\n', u'4', u'\n', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u" SEQ.=1,FOLIO='4',FILE='C:\\JMS\\creyer\\04-10097-1\\task179970\\10097-1-kg.htm',USER='creyer',CD='Sep  1 01:08 2004' ", u'\n', u'\n', u'\n', u'\n', u'GRAPHIC\n', u'3\n', u'g100971kgimage002.gif\n', u'GRAPHIC\n', u'\nbegin 644 g100971kgimage002.gif\nM1TE&.#=ATP!)`\'OGO]NAU,N+#APX@3)]P!(4*$"XT?1X;;-GQA$`BQ8', u'5+F?KV\\SMG.8MYHE;_>=?*@+,(6.`L"":8\nMGF7_7:,@3!H)\\AMH$$#VFX65::3#A15V"-F\'\'G;(X83K725', u'7BWQ)EMDPCD&@4JOU79!;;5Q^1B99$*PWT)DCHFF>/?K%1;-`VMFEED+Z\nM**8713.AII%ZUA*DGVYJ:4)E9,H89)AV9FIG"27_PJJJM*Z:Z04Z``4;EY,U\nMMJA!9`K:99=N1O!HG\\-.2F5DPO(JVYH+?;\'GL+(5&\\&OU]!6;:]]"NHMEU3Z\nM62BSDR\'*K607W"8379\\IT*H"%]\'P::O`83IOK2-)"\\&KMZJY%"*E[ALJOUO=\nM2^_!D.*:D!>S(NSPK654%Z>SP#FF;D+4(HMM07?RV=C%!6D[*)D;"_2FF1DO\nM._*$L\\F),@38?G&FF,!96_.VQ5Z@LP4@Y_1%J!2"5J)!O#D*-\'`K>1&PT8QM\nM+##3M);\\L[V>S7IAK@8Q_\'2\'MI:LTAL\'$[ZUC>!55Z=Y][8GMGX\'GZ+5.8@.L)LTHB\nMXZESA1=X_5RX`C_JN4^D\'NVXTD', u'(%*&*0BQI/(S4UO@DO62F06P', u';36,60@/(\'.L:JX.:\nMA?^L@;RM76!2P.$7K!32BK:U"CI`?%A)!.\'$&V(G6B>Z&P.)ABPY,:^+R\\-8\nM;6Y#P9$5I\'CLR9BX>E:]D2%0)H', u'VP:"TQ7:`GGPN:AQSWL]D!C083;-NL\nM\'H6M&\':H.+ZKEP!%>(T>]@\\"E>G,(/LWOVOPSU:MHL$.-,G)BPAP5A]ZVT+Z\nMM2I1XF06Q>O315(I+LUI*X1^&T2>!")+8U7P/X!35PB]9$(\'$HN$=-IB03"(\nMN,AX+4P?LES3', u'YYL&)B\\\nMYLE&6#DFF5(Q,?Y>H(/8G"[9T&]"34)`D!8=)', u'KQ\nMJB`%G1FANG0E@/I3?ZQTX/?RM%.9315/QP2?R`RE,\\VQA"*ZP]2QWH80=\';.\nM4MD,B?_T>"R)Z)`S!IDFOZJ8-T.N56P+JZ(DB82(LZ7M/VG[4=DJLIFW9JHC\nM.F"586$%16#)$3A\\;%[/H-H\\@:K0L2L#5T\':^*8Q>71[^70,3I2GU,F>46>V\nM*9]I:X+*1^9QA_\nMS1(I*U3)VMG45O;CB9:B"LA1RE$RCN/8+AEID#(ZSR"+*V883TNG\\0J$F*%M\nMC`EELL\'B9?', u'4V$JN*YSU', u'S!T3O7.9.O.O`-PH*M))#TU6!.D>!T`8TDSVQLS86\nM9G&Y"?]5NR0P3-9+&XIRZ;TIM!`S$_C:&6*+($7>FGY1"BH_PA7!L=%RUO3:\nMH:;$4(>3C*YQ;;=;/-Z.;+0CLR$LE+JA09E,^C-*;DQ*8^H/S-!3[/M:#UN3\'6[:\\58\nM4=AU$&1RU3Z:TWDJ', u"Z8R=%ZV8P(?#2*2$*=,$%U%O+#3PX$Q*\nM(OIBN%20J55?=06_+^409`C'BDEFV=JKJF;'UPGRA#U", u'8\\X5!U.=K]8F/BVX^TQWXO`8_KT&BST19>]LZW8LY^K[%_"9Z+NCI\nM+HF&>Z8N("`7"4!F^T]?!U&E\'?6(1SH"N]=K"_6RF[VQI=\'PE-1.ZNNP/>UN\nMC_O:Y6[VNMO][GC/N]Z1@_:^HWSN@&][X.$^>+\\+;^^(3[SB%\\_XQL?$\\&^\'\nM/-T)+_C*4_[RDL>2XS?/^', u']*6_HEY`S_K6N_[UL/\\)\n/Z6>/>MJKWO:1STA````[\n`\nend\n\n', u'\n', u'\n', u'\n-----END PRIVACY-ENHANCED MESSAGE-----\n']